Heme-induced lung injury in human precision cut lung slices: a new model for acute lung injury.

IF 5.8 2区 医学 Q1 Medicine
Namrata Kewalramani, Carlos Machahua, Thomas Michael Marti, Cas Zandbergen, Savvina Chortarea, Jessica Beretta-Piccoli, Christophe von Garnier, Patrick Dorn, Kleanthis Fytianos, Manuela Funke-Chambour
{"title":"Heme-induced lung injury in human precision cut lung slices: a new model for acute lung injury.","authors":"Namrata Kewalramani, Carlos Machahua, Thomas Michael Marti, Cas Zandbergen, Savvina Chortarea, Jessica Beretta-Piccoli, Christophe von Garnier, Patrick Dorn, Kleanthis Fytianos, Manuela Funke-Chambour","doi":"10.1186/s12931-025-03191-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Acute respiratory distress syndrome (ARDS) causes high mortality and has no specific pharmacological treatment. Scarcity of drugs against ARDS is in part due to the lack of models for ARDS. As raised serum heme levels are associated with higher mortality in patients with ARDS, we hypothesised that circulating heme contributes to ARDS pathology and can induce lung injury resembling human disease. We aimed to develop a new model for acute lung injury and ARDS research with heme-induced injury in human precision cut lung slices (PCLS).</p><p><strong>Methods: </strong>We analysed heme and its degrading enzymes along with inflammatory cytokines in patients with coronavirus disease 2019 (COVID-19) and ARDS compared to healthy adult subjects. In PCLS, we studied effects of heme on cell survival, membrane integrity, the transcriptome by gene expression and the proteome by protein expression analysis or ELISA. We also tested synergistical effects with lipopolysaccharide (LPS) on cell survival in addition to heme to simulate bacterial infection.</p><p><strong>Results: </strong>Patients with COVID-19 and ARDS had increased serum levels of heme and heme oxygenase 1 (HO-1) compared to controls. In PCLS, heme induced cell death in a dose-dependent manner, stimulated pro-inflammatory and injury signals and triggered changes to the extracellular matrix (ECM). Comparative analyses of the lung transcriptomic and proteomic signatures revealed 27 common markers (log2 fold change greater than 1, at adjusted (adj) p-value < 0.05 significant), most of which were inflammatory. Similar inflammatory cytokines were raised in blood from patients with COVID-19 and ARDS compared to controls. LPS did not increase cytotoxicity in addition to heme.</p><p><strong>Conclusion: </strong>Heme induced inflammatory cytokine release and cell death in human PCLS, resembling the patterns observed in blood samples from patients with COVID-19 and ARDS. Thus, heme-stimulated PCLS represent a novel ex vivo model for mechanistic studies for acute lung injury and ARDS.</p>","PeriodicalId":49131,"journal":{"name":"Respiratory Research","volume":"26 1","pages":"124"},"PeriodicalIF":5.8000,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11966866/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12931-025-03191-z","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Acute respiratory distress syndrome (ARDS) causes high mortality and has no specific pharmacological treatment. Scarcity of drugs against ARDS is in part due to the lack of models for ARDS. As raised serum heme levels are associated with higher mortality in patients with ARDS, we hypothesised that circulating heme contributes to ARDS pathology and can induce lung injury resembling human disease. We aimed to develop a new model for acute lung injury and ARDS research with heme-induced injury in human precision cut lung slices (PCLS).

Methods: We analysed heme and its degrading enzymes along with inflammatory cytokines in patients with coronavirus disease 2019 (COVID-19) and ARDS compared to healthy adult subjects. In PCLS, we studied effects of heme on cell survival, membrane integrity, the transcriptome by gene expression and the proteome by protein expression analysis or ELISA. We also tested synergistical effects with lipopolysaccharide (LPS) on cell survival in addition to heme to simulate bacterial infection.

Results: Patients with COVID-19 and ARDS had increased serum levels of heme and heme oxygenase 1 (HO-1) compared to controls. In PCLS, heme induced cell death in a dose-dependent manner, stimulated pro-inflammatory and injury signals and triggered changes to the extracellular matrix (ECM). Comparative analyses of the lung transcriptomic and proteomic signatures revealed 27 common markers (log2 fold change greater than 1, at adjusted (adj) p-value < 0.05 significant), most of which were inflammatory. Similar inflammatory cytokines were raised in blood from patients with COVID-19 and ARDS compared to controls. LPS did not increase cytotoxicity in addition to heme.

Conclusion: Heme induced inflammatory cytokine release and cell death in human PCLS, resembling the patterns observed in blood samples from patients with COVID-19 and ARDS. Thus, heme-stimulated PCLS represent a novel ex vivo model for mechanistic studies for acute lung injury and ARDS.

背景:急性呼吸窘迫综合征(ARDS)导致很高的死亡率,而且没有特效药物治疗。ARDS药物稀缺的部分原因是缺乏ARDS模型。由于血清血红素水平升高与 ARDS 患者死亡率升高有关,我们假设循环中的血红素会导致 ARDS 病理变化,并诱发类似人类疾病的肺损伤。我们的目标是利用血红素诱导的人体精密切片肺(PCLS)损伤,为急性肺损伤和 ARDS 研究建立一个新模型:我们分析了2019年冠状病毒病(COVID-19)和ARDS患者体内的血红素及其降解酶以及炎症细胞因子,并与健康成人进行了比较。在 PCLS 中,我们研究了血红素对细胞存活、膜完整性、基因表达转录组和蛋白质表达分析或 ELISA 蛋白质组的影响。除血红素外,我们还测试了脂多糖(LPS)对细胞存活的协同作用,以模拟细菌感染:结果:与对照组相比,COVID-19 和 ARDS 患者血清中的血红素和血红素加氧酶 1(HO-1)水平升高。在 PCLS 中,血红素以剂量依赖的方式诱导细胞死亡,刺激促炎和损伤信号,并引发细胞外基质(ECM)的变化。对肺转录组和蛋白质组特征的比较分析发现了 27 个共同标记物(log2 对折变化大于 1,调整(adj)p 值):血红素可诱导人类 PCLS 中炎性细胞因子的释放和细胞死亡,这与在 COVID-19 和 ARDS 患者血液样本中观察到的模式相似。因此,血红素刺激的 PCLS 是研究急性肺损伤和 ARDS 机理的新型体外模型。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Respiratory Research
Respiratory Research RESPIRATORY SYSTEM-
CiteScore
9.70
自引率
1.70%
发文量
314
审稿时长
4-8 weeks
期刊介绍: Respiratory Research publishes high-quality clinical and basic research, review and commentary articles on all aspects of respiratory medicine and related diseases. As the leading fully open access journal in the field, Respiratory Research provides an essential resource for pulmonologists, allergists, immunologists and other physicians, researchers, healthcare workers and medical students with worldwide dissemination of articles resulting in high visibility and generating international discussion. Topics of specific interest include asthma, chronic obstructive pulmonary disease, cystic fibrosis, genetics, infectious diseases, interstitial lung diseases, lung development, lung tumors, occupational and environmental factors, pulmonary circulation, pulmonary pharmacology and therapeutics, respiratory immunology, respiratory physiology, and sleep-related respiratory problems.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信